Valuation
- Market cap
- 342,166,000
- Revenue TTM
- $22,470,000
- Net income TTM
- $-78,620,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -349.89%
- Debt to equity
- 0.37
Trading
- Volume
- 6,378,656
- Avg volume
- 7,343,204
- Day's range
- $0.43 – $0.46
- Shares out
- 814,681,000
- Stochastic %K
- 20%
- Beta
- 0.83
- Analysts
- Sell
- Price target
- $1.43
Company profile
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin se...
Show more
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 301 515 7260
- Website
- https://www.senseonics.com
- Address
- 20451 Seneca Meadows Parkway, Germantown, United States
Latest news
No headlines yet.
